Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
collaboration with an IBD surgery program, close collaboration with the Cystic Fibrosis Center, Food Allergy and Eosinophilic Disorders Clinic, a Fontan care program, the Esophageal and Airway Treatment Center, a
-
of rapamycin) in pulmonary lymphangioleiomyomatosis (LAM). Our research portfolio also includes investigations into the mechanisms of cell-cell communication in sarcoidosis, idiopathic pulmonary fibrosis and
-
proclymphangioleiomyomatosis, adult cystic fibrosis, asthma, and allergic bronchopulmonary aspergillosis. Our studies include large collaborative tissue sample registries, industry-sponsored drug treatment trials, federally
-
fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex also has a robust clinical pipeline of
-
, including adult, pediatric, and cystic fibrosis patients. The therapist must be able to physically respond quickly to any emergent situation and be able to endure repetitive physical movement. This position
-
or growth, physiological reactions like inflammation, edema or fibrosis, general weight gain or loss, inter- and intra-fraction motion related to different organ and cavity fillings, respiration
-
biology/pluripotent stem cells Metabolism Inflammation and autoimmunity Tissue remodeling and fibrosis Cardiac/Vascular biology Recruited faculty will have opportunities to collaborate with other faculty in
-
therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex also has a robust
-
data analysis and professional skills that are necessary for bioscience research and related non-academic careers. https://www.yorkshirebiosciencedtp.ac.uk Project Description: Ribosome biogenesis is a
-
global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and conditions. The company has approved therapies for cystic fibrosis